Overview

Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetics, safety and immunogenicity of BAT2606 in healthy China male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Bio-Thera Solutions